The global market for Biologic Imaging Contrast Agent was estimated to be worth US$ 8256 million in 2023 and is forecast to a readjusted size of US$ 19890 million by 2030 with a CAGR of 13.4% during the forecast period 2024-2030

Biologic Imaging Contrast Agent - Market

Bioimaging contrast agents are a type of special drugs or compounds used in medical imaging technology. By introducing specific molecules or substances into the body, they can enhance medical images and help doctors diagnose and treat diseases. One of the future trends is the development of multimodal imaging contrast agents that can be used simultaneously in different imaging techniques to provide more comprehensive information. For example, using MRI and PET (positron emission tomography) imaging contrast agents together can provide more precise diagnostic results.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biologic Imaging Contrast Agent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Biologic Imaging Contrast Agent by region & country, by Type, and by Application.

The Biologic Imaging Contrast Agent market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Imaging Contrast Agent.

Market Segmentation

Scope of Biologic Imaging Contrast Agent - Market Report

Report Metric	Details
Report Name	Biologic Imaging Contrast Agent - Market
Forecasted market size in 2030	US$ 19890 million
CAGR	13.4%
Forecasted years	2024 - 2030
Segment by Type:	CT Contrast Reagents Magnetic Resonance Imaging (MRI) Contrast Reagents Ultrasound Contrast Reagents
Segment by Application	Hospitals Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bracco, Bayer HealthCare, Hengrui Medicine, GE Healthcare, YRPG, BeiLu Pharma, Guerbet, Starry Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biologic Imaging Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Biologic Imaging Contrast Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Biologic Imaging Contrast Agent in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Biologic Imaging Contrast Agent - Market size in 2030?

Ans: The Biologic Imaging Contrast Agent - Market size in 2030 will be US$ 19890 million.

Who are the main players in the Biologic Imaging Contrast Agent - Market report?

Ans: The main players in the Biologic Imaging Contrast Agent - Market are Bracco, Bayer HealthCare, Hengrui Medicine, GE Healthcare, YRPG, BeiLu Pharma, Guerbet, Starry Pharmaceutical

What are the Application segmentation covered in the Biologic Imaging Contrast Agent - Market report?

Ans: The Applications covered in the Biologic Imaging Contrast Agent - Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Biologic Imaging Contrast Agent - Market report?

Ans: The Types covered in the Biologic Imaging Contrast Agent - Market report are CT Contrast Reagents, Magnetic Resonance Imaging (MRI) Contrast Reagents, Ultrasound Contrast Reagents

1 Market Overview

1.1 Biologic Imaging Contrast Agent Product Introduction

1.2 Global Biologic Imaging Contrast Agent Market Size Forecast

1.2.1 Global Biologic Imaging Contrast Agent Sales Value (2019-2030)

1.2.2 Global Biologic Imaging Contrast Agent Sales Volume (2019-2030)

1.2.3 Global Biologic Imaging Contrast Agent Sales Price (2019-2030)

1.3 Biologic Imaging Contrast Agent Market Trends & Drivers

1.3.1 Biologic Imaging Contrast Agent Industry Trends

1.3.2 Biologic Imaging Contrast Agent Market Drivers & Opportunity

1.3.3 Biologic Imaging Contrast Agent Market Challenges

1.3.4 Biologic Imaging Contrast Agent Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Biologic Imaging Contrast Agent Players Revenue Ranking (2023)

2.2 Global Biologic Imaging Contrast Agent Revenue by Company (2019-2024)

2.3 Global Biologic Imaging Contrast Agent Players Sales Volume Ranking (2023)

2.4 Global Biologic Imaging Contrast Agent Sales Volume by Company Players (2019-2024)

2.5 Global Biologic Imaging Contrast Agent Average Price by Company (2019-2024)

2.6 Key Manufacturers Biologic Imaging Contrast Agent Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Biologic Imaging Contrast Agent Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Biologic Imaging Contrast Agent

2.9 Biologic Imaging Contrast Agent Market Competitive Analysis

2.9.1 Biologic Imaging Contrast Agent Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Biologic Imaging Contrast Agent Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Imaging Contrast Agent as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 CT Contrast Reagents

3.1.2 Magnetic Resonance Imaging (MRI) Contrast Reagents

3.1.3 Ultrasound Contrast Reagents

3.2 Global Biologic Imaging Contrast Agent Sales Value by Type

3.2.1 Global Biologic Imaging Contrast Agent Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Biologic Imaging Contrast Agent Sales Value, by Type (2019-2030)

3.2.3 Global Biologic Imaging Contrast Agent Sales Value, by Type (%) (2019-2030)

3.3 Global Biologic Imaging Contrast Agent Sales Volume by Type

3.3.1 Global Biologic Imaging Contrast Agent Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Biologic Imaging Contrast Agent Sales Volume, by Type (2019-2030)

3.3.3 Global Biologic Imaging Contrast Agent Sales Volume, by Type (%) (2019-2030)

3.4 Global Biologic Imaging Contrast Agent Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Clinics

4.1.3 Other

4.2 Global Biologic Imaging Contrast Agent Sales Value by Application

4.2.1 Global Biologic Imaging Contrast Agent Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Biologic Imaging Contrast Agent Sales Value, by Application (2019-2030)

4.2.3 Global Biologic Imaging Contrast Agent Sales Value, by Application (%) (2019-2030)

4.3 Global Biologic Imaging Contrast Agent Sales Volume by Application

4.3.1 Global Biologic Imaging Contrast Agent Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Biologic Imaging Contrast Agent Sales Volume, by Application (2019-2030)

4.3.3 Global Biologic Imaging Contrast Agent Sales Volume, by Application (%) (2019-2030)

4.4 Global Biologic Imaging Contrast Agent Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Biologic Imaging Contrast Agent Sales Value by Region

5.1.1 Global Biologic Imaging Contrast Agent Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Biologic Imaging Contrast Agent Sales Value by Region (2019-2024)

5.1.3 Global Biologic Imaging Contrast Agent Sales Value by Region (2025-2030)

5.1.4 Global Biologic Imaging Contrast Agent Sales Value by Region (%), (2019-2030)

5.2 Global Biologic Imaging Contrast Agent Sales Volume by Region

5.2.1 Global Biologic Imaging Contrast Agent Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Biologic Imaging Contrast Agent Sales Volume by Region (2019-2024)

5.2.3 Global Biologic Imaging Contrast Agent Sales Volume by Region (2025-2030)

5.2.4 Global Biologic Imaging Contrast Agent Sales Volume by Region (%), (2019-2030)

5.3 Global Biologic Imaging Contrast Agent Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Biologic Imaging Contrast Agent Sales Value, 2019-2030

5.4.2 North America Biologic Imaging Contrast Agent Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Biologic Imaging Contrast Agent Sales Value, 2019-2030

5.5.2 Europe Biologic Imaging Contrast Agent Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Biologic Imaging Contrast Agent Sales Value, 2019-2030

5.6.2 Asia Pacific Biologic Imaging Contrast Agent Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Biologic Imaging Contrast Agent Sales Value, 2019-2030

5.7.2 South America Biologic Imaging Contrast Agent Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Biologic Imaging Contrast Agent Sales Value, 2019-2030

5.8.2 Middle East & Africa Biologic Imaging Contrast Agent Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Biologic Imaging Contrast Agent Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Biologic Imaging Contrast Agent Sales Value

6.2.1 Key Countries/Regions Biologic Imaging Contrast Agent Sales Value, 2019-2030

6.2.2 Key Countries/Regions Biologic Imaging Contrast Agent Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Biologic Imaging Contrast Agent Sales Value, 2019-2030

6.3.2 United States Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Biologic Imaging Contrast Agent Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Biologic Imaging Contrast Agent Sales Value, 2019-2030

6.4.2 Europe Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Biologic Imaging Contrast Agent Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Biologic Imaging Contrast Agent Sales Value, 2019-2030

6.5.2 China Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

6.5.3 China Biologic Imaging Contrast Agent Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Biologic Imaging Contrast Agent Sales Value, 2019-2030

6.6.2 Japan Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Biologic Imaging Contrast Agent Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Biologic Imaging Contrast Agent Sales Value, 2019-2030

6.7.2 South Korea Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Biologic Imaging Contrast Agent Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Biologic Imaging Contrast Agent Sales Value, 2019-2030

6.8.2 Southeast Asia Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Biologic Imaging Contrast Agent Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Biologic Imaging Contrast Agent Sales Value, 2019-2030

6.9.2 India Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

6.9.3 India Biologic Imaging Contrast Agent Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bracco

7.1.1 Bracco Company Information

7.1.2 Bracco Introduction and Business Overview

7.1.3 Bracco Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Bracco Biologic Imaging Contrast Agent Product Offerings

7.1.5 Bracco Recent Development

7.2 Bayer HealthCare

7.2.1 Bayer HealthCare Company Information

7.2.2 Bayer HealthCare Introduction and Business Overview

7.2.3 Bayer HealthCare Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Bayer HealthCare Biologic Imaging Contrast Agent Product Offerings

7.2.5 Bayer HealthCare Recent Development

7.3 Hengrui Medicine

7.3.1 Hengrui Medicine Company Information

7.3.2 Hengrui Medicine Introduction and Business Overview

7.3.3 Hengrui Medicine Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Hengrui Medicine Biologic Imaging Contrast Agent Product Offerings

7.3.5 Hengrui Medicine Recent Development

7.4 GE Healthcare

7.4.1 GE Healthcare Company Information

7.4.2 GE Healthcare Introduction and Business Overview

7.4.3 GE Healthcare Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

7.4.4 GE Healthcare Biologic Imaging Contrast Agent Product Offerings

7.4.5 GE Healthcare Recent Development

7.5 YRPG

7.5.1 YRPG Company Information

7.5.2 YRPG Introduction and Business Overview

7.5.3 YRPG Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

7.5.4 YRPG Biologic Imaging Contrast Agent Product Offerings

7.5.5 YRPG Recent Development

7.6 BeiLu Pharma

7.6.1 BeiLu Pharma Company Information

7.6.2 BeiLu Pharma Introduction and Business Overview

7.6.3 BeiLu Pharma Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

7.6.4 BeiLu Pharma Biologic Imaging Contrast Agent Product Offerings

7.6.5 BeiLu Pharma Recent Development

7.7 Guerbet

7.7.1 Guerbet Company Information

7.7.2 Guerbet Introduction and Business Overview

7.7.3 Guerbet Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Guerbet Biologic Imaging Contrast Agent Product Offerings

7.7.5 Guerbet Recent Development

7.8 Starry Pharmaceutical

7.8.1 Starry Pharmaceutical Company Information

7.8.2 Starry Pharmaceutical Introduction and Business Overview

7.8.3 Starry Pharmaceutical Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Starry Pharmaceutical Biologic Imaging Contrast Agent Product Offerings

7.8.5 Starry Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Biologic Imaging Contrast Agent Industrial Chain

8.2 Biologic Imaging Contrast Agent Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Biologic Imaging Contrast Agent Sales Model

8.5.2 Sales Channel

8.5.3 Biologic Imaging Contrast Agent Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Starry Pharmaceutical

List of Tables

Table 1. Biologic Imaging Contrast Agent Market Trends

Table 2. Biologic Imaging Contrast Agent Market Drivers & Opportunity

Table 3. Biologic Imaging Contrast Agent Market Challenges

Table 4. Biologic Imaging Contrast Agent Market Restraints

Table 5. Global Biologic Imaging Contrast Agent Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Biologic Imaging Contrast Agent Revenue Market Share by Company (2019-2024)

Table 7. Global Biologic Imaging Contrast Agent Sales Volume by Company (2019-2024) & (Kiloton)

Table 8. Global Biologic Imaging Contrast Agent Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Biologic Imaging Contrast Agent Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Biologic Imaging Contrast Agent Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Biologic Imaging Contrast Agent Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Biologic Imaging Contrast Agent

Table 13. Global Biologic Imaging Contrast Agent Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Imaging Contrast Agent as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Biologic Imaging Contrast Agent Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Biologic Imaging Contrast Agent Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Biologic Imaging Contrast Agent Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Biologic Imaging Contrast Agent Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Biologic Imaging Contrast Agent Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Biologic Imaging Contrast Agent Sales Volume by Type: 2019 VS 2023 VS 2030 (Kiloton)

Table 22. Global Biologic Imaging Contrast Agent Sales Volume by Type (2019-2024) & (Kiloton)

Table 23. Global Biologic Imaging Contrast Agent Sales Volume by Type (2025-2030) & (Kiloton)

Table 24. Global Biologic Imaging Contrast Agent Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Biologic Imaging Contrast Agent Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Biologic Imaging Contrast Agent Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Biologic Imaging Contrast Agent Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Biologic Imaging Contrast Agent Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Biologic Imaging Contrast Agent Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Biologic Imaging Contrast Agent Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Biologic Imaging Contrast Agent Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Biologic Imaging Contrast Agent Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Biologic Imaging Contrast Agent Sales Volume by Application: 2019 VS 2023 VS 2030 (Kiloton)

Table 34. Global Biologic Imaging Contrast Agent Sales Volume by Application (2019-2024) & (Kiloton)

Table 35. Global Biologic Imaging Contrast Agent Sales Volume by Application (2025-2030) & (Kiloton)

Table 36. Global Biologic Imaging Contrast Agent Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Biologic Imaging Contrast Agent Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Biologic Imaging Contrast Agent Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Biologic Imaging Contrast Agent Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Biologic Imaging Contrast Agent Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Biologic Imaging Contrast Agent Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Biologic Imaging Contrast Agent Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Biologic Imaging Contrast Agent Sales Value by Region (2019-2024) & (%)

Table 44. Global Biologic Imaging Contrast Agent Sales Value by Region (2025-2030) & (%)

Table 45. Global Biologic Imaging Contrast Agent Sales Volume by Region (Kiloton): 2019 VS 2023 VS 2030

Table 46. Global Biologic Imaging Contrast Agent Sales Volume by Region (2019-2024) & (Kiloton)

Table 47. Global Biologic Imaging Contrast Agent Sales Volume by Region (2025-2030) & (Kiloton)

Table 48. Global Biologic Imaging Contrast Agent Sales Volume by Region (2019-2024) & (%)

Table 49. Global Biologic Imaging Contrast Agent Sales Volume by Region (2025-2030) & (%)

Table 50. Global Biologic Imaging Contrast Agent Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Biologic Imaging Contrast Agent Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Biologic Imaging Contrast Agent Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Biologic Imaging Contrast Agent Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Biologic Imaging Contrast Agent Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Biologic Imaging Contrast Agent Sales Volume, (2019-2024) & (Kiloton)

Table 56. Key Countries/Regions Biologic Imaging Contrast Agent Sales Volume, (2025-2030) & (Kiloton)

Table 57. Bracco Company Information

Table 58. Bracco Introduction and Business Overview

Table 59. Bracco Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. Bracco Biologic Imaging Contrast Agent Product Offerings

Table 61. Bracco Recent Development

Table 62. Bayer HealthCare Company Information

Table 63. Bayer HealthCare Introduction and Business Overview

Table 64. Bayer HealthCare Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. Bayer HealthCare Biologic Imaging Contrast Agent Product Offerings

Table 66. Bayer HealthCare Recent Development

Table 67. Hengrui Medicine Company Information

Table 68. Hengrui Medicine Introduction and Business Overview

Table 69. Hengrui Medicine Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Hengrui Medicine Biologic Imaging Contrast Agent Product Offerings

Table 71. Hengrui Medicine Recent Development

Table 72. GE Healthcare Company Information

Table 73. GE Healthcare Introduction and Business Overview

Table 74. GE Healthcare Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. GE Healthcare Biologic Imaging Contrast Agent Product Offerings

Table 76. GE Healthcare Recent Development

Table 77. YRPG Company Information

Table 78. YRPG Introduction and Business Overview

Table 79. YRPG Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. YRPG Biologic Imaging Contrast Agent Product Offerings

Table 81. YRPG Recent Development

Table 82. BeiLu Pharma Company Information

Table 83. BeiLu Pharma Introduction and Business Overview

Table 84. BeiLu Pharma Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. BeiLu Pharma Biologic Imaging Contrast Agent Product Offerings

Table 86. BeiLu Pharma Recent Development

Table 87. Guerbet Company Information

Table 88. Guerbet Introduction and Business Overview

Table 89. Guerbet Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. Guerbet Biologic Imaging Contrast Agent Product Offerings

Table 91. Guerbet Recent Development

Table 92. Starry Pharmaceutical Company Information

Table 93. Starry Pharmaceutical Introduction and Business Overview

Table 94. Starry Pharmaceutical Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. Starry Pharmaceutical Biologic Imaging Contrast Agent Product Offerings

Table 96. Starry Pharmaceutical Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Biologic Imaging Contrast Agent Downstream Customers

Table 100. Biologic Imaging Contrast Agent Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Biologic Imaging Contrast Agent Product Picture

Figure 2. Global Biologic Imaging Contrast Agent Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Biologic Imaging Contrast Agent Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Biologic Imaging Contrast Agent Sales Volume (2019-2030) & (Kiloton)

Figure 5. Global Biologic Imaging Contrast Agent Sales Price (2019-2030) & (US$/Ton)

Figure 6. Biologic Imaging Contrast Agent Report Years Considered

Figure 7. Global Biologic Imaging Contrast Agent Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Biologic Imaging Contrast Agent Players Sales Volume Ranking (2023) & (Kiloton)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Biologic Imaging Contrast Agent Revenue in 2023

Figure 10. Biologic Imaging Contrast Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. CT Contrast Reagents Picture

Figure 12. Magnetic Resonance Imaging (MRI) Contrast Reagents Picture

Figure 13. Ultrasound Contrast Reagents Picture

Figure 14. Global Biologic Imaging Contrast Agent Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Biologic Imaging Contrast Agent Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Biologic Imaging Contrast Agent Sales Volume by Type (2019 VS 2023 VS 2030) & (Kiloton)

Figure 17. Global Biologic Imaging Contrast Agent Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Biologic Imaging Contrast Agent Price by Type (2019-2030) & (US$/Ton)

Figure 19. Product Picture of Hospitals

Figure 20. Product Picture of Clinics

Figure 21. Product Picture of Other

Figure 22. Global Biologic Imaging Contrast Agent Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Biologic Imaging Contrast Agent Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Biologic Imaging Contrast Agent Sales Volume by Application (2019 VS 2023 VS 2030) & (Kiloton)

Figure 25. Global Biologic Imaging Contrast Agent Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Biologic Imaging Contrast Agent Price by Application (2019-2030) & (US$/Ton)

Figure 27. North America Biologic Imaging Contrast Agent Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Biologic Imaging Contrast Agent Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Biologic Imaging Contrast Agent Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Biologic Imaging Contrast Agent Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Biologic Imaging Contrast Agent Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Biologic Imaging Contrast Agent Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Biologic Imaging Contrast Agent Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Biologic Imaging Contrast Agent Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Biologic Imaging Contrast Agent Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Biologic Imaging Contrast Agent Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Biologic Imaging Contrast Agent Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Biologic Imaging Contrast Agent Sales Volume (%), (2019-2030)

Figure 39. United States Biologic Imaging Contrast Agent Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Biologic Imaging Contrast Agent Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Biologic Imaging Contrast Agent Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Biologic Imaging Contrast Agent Sales Value by Application (%), 2023 VS 2030

Figure 45. China Biologic Imaging Contrast Agent Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

Figure 47. China Biologic Imaging Contrast Agent Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Biologic Imaging Contrast Agent Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Biologic Imaging Contrast Agent Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Biologic Imaging Contrast Agent Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Biologic Imaging Contrast Agent Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Biologic Imaging Contrast Agent Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Biologic Imaging Contrast Agent Sales Value by Application (%), 2023 VS 2030

Figure 57. India Biologic Imaging Contrast Agent Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Biologic Imaging Contrast Agent Sales Value by Type (%), 2023 VS 2030

Figure 59. India Biologic Imaging Contrast Agent Sales Value by Application (%), 2023 VS 2030

Figure 60. Biologic Imaging Contrast Agent Industrial Chain

Figure 61. Biologic Imaging Contrast Agent Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions